Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PROCEPT BioRobotics
PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
August 01, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024
July 15, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
June 17, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
June 03, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
May 13, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
May 06, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
May 01, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
April 29, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
April 23, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
April 04, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
April 02, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
February 27, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
February 12, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
January 08, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
November 13, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
November 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
October 16, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
October 12, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
September 20, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
September 12, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
August 22, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
August 17, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
August 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
August 01, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
July 27, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
July 11, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
April 28, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
April 27, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas
April 05, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates
April 03, 2023
From
PROCEPT BioRobotics
Via
GlobeNewswire
Tickers
PRCT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.